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Abstract
Objective: The present study aimed to identify Mollicutes infection in the reproductive system.
We also examined the microbiological, biochemical, and antimicrobial profiles of Mollicutes infec-
tion, which are potentially associated with clinical reproductive abnormalities causing infertility
in couples.
Methods: Thirty-seven couples who were attending an infertility clinic were enrolled. Detection
of genital mycoplasmas was performed in cervicovaginal samples or male urethral swabs.
Microbiological culture and biochemical and antimicrobial profiles were characterized using a
Mycoplasma kit. The results were associated with reproductive abnormalities, as assessed by
medical specialists from the infertility clinic.
Results: Up to 28.3% of all biological samples (n¼ 74) showed positive cultures. Bacterial
isolates were Ureaplasma urealyticum (71.4%), Mycoplasma hominis (9.5%), or coinfections
(19%). Most Mollicutes showed significant resistance to fluoroquinolones, macrolides, and tetra-
cycline; and showed susceptibility to doxycycline, josamycin, and pristinamycin. The presence of
resistant strains to any antibiotic was significantly associated with genital abnormalities (v2 test,
relative risk¼ 11.38 [95% confidence interval: 5.8–22.9]), particularly in women. The highest
statistical association was found for macrolide-resistant strains.
Conclusion: The microbiological antibiotic resistance profile is epidemiologically associated with
abnormalities of the reproductive system in couples attending an infertility clinic.
Keywords
Mollicutes, antimicrobial resistance profile, reproductive abnormalities, infertility, bacterial iso-
late, Mycoplasma
Date received: 16 November 2018; accepted: 15 January 2019
Introduction
The World Health Organization, as
well as the European Society of Human
Reproduction and Embryology, define
infertility as a disease of the reproductive
system that leads to the inability to achieve
a pregnancy after 12 months or longer with
unprotected sex. Infertility is currently a
problem of global distribution and increas-
ing magnitude. An estimated 20% to 35%
of all couples who wish to procreate have
an infertility disorder.1
The main causes of infertility in couples
include female endocrine disorders, ovulato-
ry dysfunction, tubal and peritoneal dis-
eases, and male endocrine and testicular
disorders and seminal obstruction caused
by sexually transmitted infections. Notably,
the male and female reproductive systems
are suitable for growth of various pathogen-
ic and non-pathogenic microorganisms.2
Genital mycoplasmas belong to an inde-
pendent taxonomic class called Mollicutes
and Mycoplasmataceae. This bacterial family
includes Mycoplasma spp., Mycoplasma hom-
inis, Mycoplasma genitalium, and Ureaplasma
urealyticum. These species may cause oligo-
symptomatic genital infections in women
and men of reproductive age, such as urethri-
tis, urinary tract infections, chorioamnionitis,
pelvic inflammatory disease, and sperm cell
disorders. Complications from these infections
may lead to infertility.3,4
In Mexico, the National Health System
has recognized the importance of infertility
as a public health problem. However, only a
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few studies have addressed infertility
causes, and mainly evaluated non-
infectious etiologies. Therefore, evaluating
the potential participation of sexually trans-
mitted infections is important because
Mollicutes, such as U. urealyticum and
M. hominis, have been identified in semen
samples and endocervical exudates
from Mexican couples with infertility.5
Furthermore,M. hominis has been reported
in 24.2% of infertile males with sperm
abnormalities, whereas U. urealyticum has
been reported in 86.8% of infertile females
with tubular abnormalities.6
Antimicrobial therapy for Mollicutes
genital mycoplasmas includes quinolones,
tetracyclines, and macrolides as the drugs
of choice. However, the indiscriminate use
of antibiotics has promoted development of
antibiotic-resistant strains.7 Nonetheless,
characterization of antibiotic resistance
and its association with reproductive disor-
ders in Mexican couples with infertility
remain unclear. Therefore, this study
aimed to identify Mollicutes infection in
the reproductive system, as well as charac-
terize its microbiological, biochemical, and
antimicrobial profiles.
Patients and methods
Study population
In this cross-sectional study, 37 infertile cou-
ples were included from the Department of
Assisted Reproduction National Medical
Center “20 de Noviembre”, ISSSTE,
Mexico City, Mexico between August 2015
and February 2016. Characteristics of the
population, such as age, age at initiation of
sexual activity, number of sexual partners,
marital status, and infertility time, were col-
lected from clinical records. Patients with
anatomical alterations, genetic diseases,
and endocrine disorders, and couples under
antimicrobial treatment were excluded for at
least 2 weeks before recruitment.
This study was designed and performed
according to ethical guidelines of the 1975
Declaration of Helsinki. The study was
approved by the Local Committees of
Research, Ethics in Research, and
Biosafety of the Centro Me´dico Nacional
“20 de Noviembre”, ISSSTE, Mexico City
(Protocol ID No. 033.2013). All partici-
pants provided written informed consent.
Cervicovaginal samples
Samples were collected by specialized and
experienced medical personnel according
to the routine procedure in the
Department of Reproductive Biology. For
cervicovaginal exudate, the sample was
taken by placing the patient in a gynecolog-
ical position, and a sterile mirror was
inserted into the vagina, which was lubri-
cated with sterile water and heated to
37C if necessary. The use of commercial
lubricants or an antiseptic was avoided.
Once the cervix was located, the mirror
was fixed by opening the valves and a vag-
inal sac or cervix sample was taken, as
appropriate. During routine sampling, two
swabs were obtained for replicates of the
samples. With the first swab, direct smears
were stained with the Gram technique (to
evaluate the Nugent criteria). The second
swab was used for transport media R1
broth (Mycoplasma Gallery IST2) to
detect the presence of mycoplasmas.8
Urethral swabs
Patients were asked to retract the penis
foreskin and keep it in this position
throughout the procedure. The medical per-
sonnel used sterile cotton or gauze to clean
the opening of the urethra at the tip of the
penis. To collect the sample, a cotton appli-
cator (cotton swab) was gently inserted
approximately 2 cm into the urethra and
turned. To obtain a good sample, the
test was performed at least 2 hours
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after urinating. The swab was placed in R1
broth (Mycoplasma Gallery IST2) to initi-
ate isolation of mycoplasmas.
Microbiological culture
The liquid media for U. urealyticum and
M. hominis were inoculated from the trans-
port medium R1 (Mycoplasma IST2 kit,
Biome´rieux, Marcy l’Etoile, France)
A total of 150 mL of the broth transport
medium R1, containing the clinical
sample, were inoculated. To perform phe-
notypic identification of U. urealyticum,
urea broth was used, which contained
medium base (pleuropneumonia-like organ-
ism broth), yeast extract, horse serum, and
urea. To determine growth of this microor-
ganism, phenol red was added to the culture
medium because it turns from red to intense
raspberry red in the presence of urease and
ammonium production. Similarly, culture
medium specific for M. hominis had argi-
nine added. When metabolized, arginine
produces an alkaline compound that turns
phenol red to raspberry red. Culture media
were incubated at 37C until the phenol red
indicator changed color. Solid cultures were
performed using a rich medium supple-
mented with horse serum, yeast extract,
and cysteine, and either urea substrates
for U. urealyticum or arginine for M. hom-
inis was added. Culture media were inocu-
lated by adding three drops of 5 mL each.
The inoculated plates were incubated at
37C in 5% CO2, and were checked daily
for colonial morphology of a “fried egg” for
M. hominis or a “sea urchin” for U. urealy-
ticum. A culture was considered negative if
no colony growth was obtained after 15
days of incubation.9 Strategies to minimize
the chance of non-specific results included
the following: 1) addition of polymyxin B,
amphotericin B, and penicillin to cultures;
2) parallel assays using positive control of
Mollicutes, and 3) all of the growth
obtained was further characterized by the
IST2 gallery to evaluate specificity.
Biochemical characterization
The Mycoplasma IST2 gallery was used
according to the manufacturer’s instruc-
tions as follows. A swab with the sample
was placed in the transport medium R1
broth (3 mL). The broth was mixed with
the lyophilisate R2 provided by the gallery,
and this contained the substrates necessary
for development of microorganisms.
A volume of 50 mL was distributed to
each of the domes of the 22 tests that
were divided into three sections. In the
first section, phenotypic detection of
M. hominis and U. urealyticum was per-
formed. In the second section, microorgan-
isms were quantified, with determination of
whether the sample contained a concen-
tration> 104 change in color units (CCU)/
sample. This indicated the importance of
the presence of these microorganisms. In
the last section, sensitivity tests were per-
formed for different antimicrobials, and
sensitivity was indicated by a change in
color from yellow to red. Finally, after inoc-
ulation of each of the domes, two or three
drops of sterile mineral oil were added. The
gallery was incubated at 37C and the
results were recorded at 24 and 48 hours.10
Clinical evaluation
Hysterosalpingography was performed in a
radiology room. The patients lay on a table
under an X-ray machine and placed their
feet in stirrups. An instrument called a spec-
ulum was inserted into the vagina. After
cleaning the cervix, the doctor passed a
thin tube (catheter) through it. A dye (con-
trast medium) was passed through this
tube, and it filled the uterus and fallopian
tubes. X-rays were then taken. This con-
trast medium enabled these areas to be
viewed on X-rays.11 In spermatobioscopy,
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the patient was asked for at least 3 days of
sexual abstinence and not to perform
intense physical exercise days before the
analysis. The patient was required to mas-
turbate in a clean room near the laboratory
to process the sample and thus avoid ther-
mal shock. A macroscopic study of the
semen was performed to evaluate liquefac-
tion, appearance, volume, pH, and viscosi-
ty. A microscopic study was performed
later to evaluate sperm concentrations,
presence of leukocytes, motility, vitality,
and sperm morphology.12 All of the study
population was routinely searched for other
genital pathogens, such as Neisseria and
Chlamydia, with negative results.
Statistical analysis
Data were analyzed using the Statistical
Package for Social Sciences v.18.0. (SPSS
Inc., Chicago, IL, USA) for Windows.
A P value 0.05 (two-tailed) was considered
to be statistically significant. Qualitative var-
iables are described as mean and standard
deviation, and were compared using the
Student’s t-test. The chi-square test was
calculated in the independence test of quali-
tative random variables.
Results
The study population consisted of
74 patients (37 men and 37 women) who
were recruited from the infertility clinic,
aged 31 to 34 years old. Most of the
patients had begun an active sexual life
from the age of 18 years old. The most fre-
quent number of sexual partners was more
than three. There was a significant differ-
ence between sexual practices of men and
women (p< 0.001). A significantly higher
proportion of men showed asymptomatic
infections then did women (p< 0.001).
The most prevalent genitourinary symptom
was secretion (women) and dysuria
(men). For the time of infertility, most
patients showed longer than 5 years. The
detailed sociodemographic characteristics
are shown in Table 1.
Characterization of specimens
Seventy-four samples of cervical and ure-
thral exudates were collected, and the
Table 1. Demographic and clinical characteristics of couples with infertility.
Men
(n¼ 37)
Women
(n¼ 37) p value
Age (years) 34.7 0.21 31.5 1.4 N.S.
Start of sexual life< 18 years 12 (32.4) 5 (13.5) 0.04
Number of previous sexual partners
1–2 5 (13.5) 18 (48.6)
3–4 17 (45.9) 14 (37.8) 0.001
5 16 (43.2) 5 (13.5)
Genitourinary symptoms
Symptomatic* 11 (29.7) 28 (75.7) <0.001
Asymptomatic 26 (70.3) 9 (24.3)
Years of infertility#
<5 years 29 (78.3) <0.001
5 years 8 (21.6)
Quantitative data are shown as mean standard deviation. Qualitative data are shown as number (%). #Determined by the
number of couples. Statistical analysis was performed with Fisher’s test. *Symptomatic was considered as any combination
of secretion, itching, and/or burning when urinating.
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analysis included two methods of character-
ization: microbiological (culture conditions,
Nugent criteria occurred in< 10%, and
related to M. hominis) and biochemical
(by the Mycoplasma IST2 kit) (Figure 1).
By using these approaches, we observed a
100% diagnostic agreement between both
methods, where genital mycoplasmas were
isolated from 21 (28.3%) samples, either as
a single microorganism or as a coinfection
with both types of genital mycoplasmas.
Notably, U. urealyticum was found in 15
of 21 samples as a single infective bacteri-
um. U. urealyticum was found as a coinfec-
tion with M. hominis in four samples.
M. hominis was found in two samples.
The presence of genital mycoplasmas, as
a shared infection between couples, was
observed in 76% of patients. Notably, gen-
ital mycoplasmas showed a threshold con-
centration of 104 CCU, which indicated
active infection in all of the patients.
Additionally, biochemical characterization
was performed to detect antibiotic resistance
profiles of the microorganisms. These micro-
organisms included fluoroquinolone-resistant
strains of U. urealyticum, particularly to cip-
rofloxacin (86.6%) and ofloxacin (80%),
whereas they were highly sensitive to doxycy-
cline, josamycin, and pristinamycin. M. hom-
inis strains were completely resistant to
macrolides (erythromycin, tetracycline, cla-
rithromycin, and azithromycin). However,
fluoroquinolone resistance was found in
50% of cases and the strains were highly sus-
ceptible to doxycycline, josamycin, and pris-
tinamycin. When U. urealyticum and
M. hominis were found as coinfection, resis-
tance to most antibiotics was observed,
mainly to fluoroquinolones and macrolides
(Table 2).
Association of antibiotic resistance in
Mollicutes with the clinical condition of
patients with infertility
Clinical conditions that are associated
with infertility in males, such as astheno-
spermia and azoospermia, showed a
higher prevalence in the population who
was infected with genital mycoplasmas
(both p< 0.001). However, those without
Figure 1. Characterization of clinical specimens. Left panels: bacteria growing in pleuropneumonia-like
organism medium. (a) Mycoplasma hominis shows a characteristic “fried egg” shape. (b) Ureaplasma urealy-
ticum shows a “sea urchin” shape. Right panels: Biochemical characterization using the Mycoplasma IST2 kit.
The first three domes on the left are intended for identification purposes. The next two domes are intended
for quantification purposes. The last nine domes are intended for characterization of antibiotic resistance,
according to color development: yellow (susceptible) or red (resistant).
6 Journal of International Medical Research 0(0)
genital mycoplasma infection did not pre-
sent with any abnormalities. In women, uni-
lateral and bilateral tubular obstruction,
premature rupture of the fetal membranes,
and ectopic pregnancies occurred signifi-
cantly more frequently in patients who
were positive for genital mycoplasma infec-
tion than in those who were not positive for
genital mycoplasma infection (all p< 0.001)
(Table 3).
Furthermore, a higher prevalence and
significant association (chi-square test,
p< 0.0001) was found between microorgan-
isms that were resistant to any antibiotic
and the presence of any genital abnormality
(relative risk [RR]¼ 11.38, 95% confidence
interval [CI]: 5.8–22.9, p< 0.0001,
Appendix 1). This finding was also
observed for most of the antibiotic groups
tested, including tetracyclines (RR¼ 6.5, 95%
CI: 2.1–19.5, p< 0.0001), macrolides (RR¼
37.7, 95% CI: 5.25–271, p< 0.0001),
quinolones (RR¼ 1.1, 95% CI: 0.81–1.6,
p¼ 0.25), and pristinamycin (RR¼ 9,
95% CI: 0.85–94.9, p¼ 0.19).
Discussion
The main finding of the present study was
the higher prevalence of Mollicutes that was
Table 2. Ureaplasma urealyticum and Mycoplasma hominis antimicrobial profile of all samples.
Ureaplasma urealyticum
(n¼ 15)
Mycoplasma hominis
(n¼ 2)
Ureaplasma urealyticum
þMycoplasma hominis
(n¼ 4)
Antimicrobial S R S R S R
Doxycycline 15 (100) 0 (0) 2 (100) 0 (0) 4 (100) 0 (0)
Tetracycline 3 (20) 12 (80) 0 (0) 2 (100) 2 (50) 2 (50)
Josamycin 15 (100) 0 (0) 2 (100) 0 (0) 2 (50) 2 (50)
Erythromycin 13 (86.6) 2 (13.3) 0 (0) 2 (100) 2 (50) 2 (50)
Azithromycin 13 (86.6) 2 (13.3) 0 (0) 2 (100) 0 (0) 4 (100)
Clarithromycin 14 (93.3) 1 (6.66) 0 (0) 2 (100) 0 (0) 4 (100)
Ofloxacin 3 (20.0) 12 (80.0) 0 (0) 2 (100) 0 (0) 4 (100)
Ciprofloxacin 2 (13.3) 13 (86.6) 0 (0) 2 (100) 0 (0) 4 (100)
Pristinamycin 15 (100) 0 (0) 2 (100) 0 (0) 0 (0) 0 (0)
Qualitative data are shown as number (%). Samples included were individual and mixed cervicovaginal and ure-
thral samples.
Table 3. Clinical condition associated with genital mycoplasma infection (n¼ 37).
AS* AZ* OL OL-1 TO# PRM# EP# NCE C
M. hominis 0 (0) 0 (0) 0 (0) 0 (0) 2 (16.6) 0 (0) 0 (0) 0 (0) 0 (0)
U. urealyticum 5 (55.5) 2 (22.2) 0 (0) 0 (0) 8 (66.6) 8 (66.6) 5 (41.6) 1 (8.3) 1 (8.3)
M. hominis and
U. urealyticum
0 (0) 0 (0) 1 (11.1) 1 (11.1) 2 (16.6) 0 (0) 0 (0) 0 (0) 0 (0)
Data are shown as number (%). The symbols indicate conditions associated with infection of genital mycoplasmas in men
(*) and women (#), p< 0.001. AS, asthenospermia; AZ, azoospermia; OL, oligoasthenozoospermia; OL1, oligoastheno-
teratozoospermia; TO, tubular obstruction; EP, ectopic pregnancy; PRM, premature rupture of the membranes; NCE,
nonspecific chronic endocervicitis; C, cervicitis; U., Ureaplasma; M., Mycoplasma.
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resistant to any antibiotic within the group
of patients with genital abnormalities
among couples who were attending an
infertility clinic. The study population was
characterized by couples aged 31 to 34
years. There was a significant difference
between sexual practices of men and
women. More than two thirds of men
showed asymptomatic infections and
approximately three quarters of the
women were symptomatic. The higher prev-
alence of infection in women with identifi-
able clinical conditions related to infertility
is consistent with previous reports.13,14 This
finding supports the epidemiological associ-
ation between Mollicutes infection and
infertility in women.
Similar to previous studies, we observed
that U. urealyticum was the most prevalent
(71%) species that was isolated in samples
of the cervix and urethra from the studied
couples. The reported prevalence of U. ure-
alyticum cervical infection in similar popu-
lations varies from 50% to 80%,15 whereas
its prevalence may reach up to 90% in
women who are sexually active. M. hominis
infection was the next most prevalent infec-
tion in our study. The presence of M. hom-
inis is relevant because it contributes to
polybacterial infection known as “bacterial
vaginosis”. This condition is considered a
dysbiosis related to the absence of
Lactobacilli and an increase in vaginal pH
that favors further infections. In fact, syn-
ergism between M. hominis and other
microorganisms causing bacterial vaginosis
has been suggested. Similarly, studies in the
Italian population have reported a higher
prevalence of U. urealyticum and M. homi-
nis, and a possible association of M. homi-
nis with bacterial vaginosis.16–20
In some patients, we observed coinfec-
tion of Ureaplasma spp. with M. hominis,
which is expected. Ureaplasma spp. and
M. hominis may become opportunistic
agents under immunocompromising situa-
tions, and rapidly increase their bacterial
load (determined by quantitative PCR
and/or microbiological culture). This is
considered a useful marker of clinically
significant infection.21 Furthermore, coin-
fection with other microorganisms is con-
sidered important information because of
potential interactions with Mollicutes. An
example of this situation is that coinfection
of human papilloma virus and Mollicutes
has been suggested to accelerate tissue
damage, leading to organ dysfunction.
M. hominis and Ureaplasma spp. have
been implicated in a wide variety of infec-
tions that may lead to infertility. Female
chronic genital infection might induce adhe-
sions to the inside and outside of fallopian
tubes. This results in obstruction of the fal-
lopian tube and is an obstacle for union of
the sperm and egg. Infection is also related
to ectopic pregnancies and premature rup-
ture of the membranes, leading to a lower
possibility of pregnancy. This is consistent
with our finding of a higher prevalence of
genital Mollicutes in women who had any
reproductive abnormality. Similarly, a
Danish study showed a significant correla-
tion between the presence of M. hominis
and U. urealyticum with tubal abnormalities
in a population of 304 infertile women.22
Genito-urinary infections, such as urethri-
tis, prostatitis, and other inflammatory pro-
cesses, are also related to 15% of male
infertility.23 Mollicutes is particularly asso-
ciated with sperm abnormalities, such as
aberrant motility, deficient mitochondrial
function, and loss of DNA integrity.24–27
Increased formation of hydrogen peroxide
and reactive oxygen species might induce
peroxidation of sperm lipids, which causes
an internal alteration that makes them inca-
pable of moving.28 U. urealyticum has been
described as the most frequent species relat-
ed to male reproductive system abnormali-
ties.29–31 Consistently, U. urealyticum is the
most frequent species in men with infertili-
ty; although most of our male affected pop-
ulation did not show any genital infections.
8 Journal of International Medical Research 0(0)
This finding is in contrast to a previous
report, which showed that the presence of
U. urealyticum and M. hominis was related
to impaired density of semen, and abnormal
sperm vitality and motility in infertile
men.8,32 Such differences in observations
may be explained by methodological varia-
tions in the tests used to evaluate sperm.
With regard to the antibiotic profile,
U. urealyticum isolates showed a high rate
of fluoroquinolone resistance; while
M. hominis showed resistance to macrolides.
These profiles are consistent with previous
reports9–33 and may be related to the wide-
spread use of fluoroquinolones within the
Mexican population, especially as therapy
for urinary infections.33 Moreover, Mexican
official therapeutic guidelines32 recommend
that symptomatic sexually transmitted infec-
tions (where Neisseria gonorrhoeae,
Chlamydia trachomatis,M. hominis, U. urea-
lyticum, and other facultative anaerobic bac-
teria have been identified by culture media or
quantitative PCR) be treated with fluoroqui-
nolones or clindamycin for ambulatory
patients, or cephalosporin and doxycycline
in case of in-hospital treatment. This may
affect prognosis of the ambulatory popula-
tion because of the antibiotic resistance pro-
file, which may lead to additional resistance
to antimicrobials, therapeutic failure, and
chronic infection with potential complica-
tions. Interestingly, U. urealyticum and M.
hominis isolates were highly sensitive to
agents, such as doxycycline, josamycin, and
pristinamycin, which is consistent with the
pattern of antibiotic resistance found in
other populations.11,12,18,34 Generally, our
findings support the benefit of routine isola-
tion of microorganisms as part of a compre-
hensive evaluation and therapy during
infertility studies.
Interestingly, we found that the presence
of antibiotic-resistant strains of genital
Mollicutes were associated with reproduc-
tive abnormalities in the study population,
particularly in women. Previous reports
have described the distribution of
antibiotic-resistant strains of genital
Mollicutes in populations with infertili-
ty.35–38 However, to the best of our knowl-
edge, this is the first study to evaluate the
role of bacterial antibiotic resistance in clin-
ical reproductive abnormalities in couples
attending an infertility clinic. Although
the precise mechanism remains unclear, we
believe that a relation of antibiotic-resistant
strains with reproductive abnormalities and
infertility is feasible. This is because novel
mechanisms of antibiotic-resistant bacteria
suggest induction of microbiota dysbiosis,
which facilitates bacterial migration
and translocation, and is potentially associ-
ated with higher damage in reproduc-
tive organs.39,40
In conclusion, the microbiological anti-
biotic resistance profile is associated
with abnormalities of the reproductive
system in Mexican couples attending an
infertility clinic.
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Appendix 1. Antimicrobial resistance profile and genital abnormalities.
With genital abnormalities Without genital abnormalities
U. urealyticum M. hominis
U. urealyticum
þ M. hominis U. urealyticum M. hominis
U. urealyticum
þ M. hominis
S R S R S R S R S R S R
Doxycycline – – – – – – 15 (100) 0 (0) 2 (100) 0 (0) 4 (100) 0 (0)
Tetracycline 3 (20) 12 (80) – – – – – – 0 (0) 2 (100) 2 (50) 2 (50)
Josamycin – – – – – – 15 (100) 0 (0) 2 (100) 0 (0) 2 (50) 2 (50)
Erythromycin – – 0 (0) 2 (100) – – 13 (86.6) 2 (13.3) – – 2 (50) 2 (50)
Azithromycin – – 0 (0) 2 (100) 0 (0) 4 (100) 13 (86.6) 2 (13.3) – – – –
Clarithromycin – – 0 (0) 2 (100) 0 (0) 4 (100) 14 (93.3) 1 (6.66) – – – –
Ofloxacin 3 (20.0) 12 (80.0) 0 (0) 2 (100) 0 (0) 4 (100) – – – – – –
Ciprofloxacin 2 (13.3) 13 (86.6) 0 (0) 2 (100) 0 (0) 4 (100) – – – – – –
Pristinamycin – – – – – – 15 (100) 0 (0) 2 (100) 0 (0) 0 (0) 0 (0)
Qualitative data are shown as number (%). Samples included were individual and mixed cervicovaginal and urethral
samples. U., Ureaplasma; M., Mycoplasma; S, sensitive; R, resistant.
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